["{\n\"step_by_step_thinking\": \"The question is about pre-exposure prophylaxis against malaria. The patient is planning to travel to Ethiopia next month. According to the relevant documents, providing treatment for patients on the basis of haemoglobin level at first visit is of doubtful value. Folate supplements during pregnancy did not show any difference in obstetric complications between the two groups. Iron deficiency anaemia is common among Nigerian pregnant women and iron supplement should be given in addition to folic acid throughout pregnancy and puerperium. Hypertensive disorders are a major cause of maternal mortality, but that does not relate directly to malaria prevention. Malaria is more prevalent in developing countries like Ethiopia where the patient is traveling.\n\nThe relevant document 'Promoting maternal health in developing countries' states that 99% of all maternal deaths occur in developing countries. This suggests that it is likely that the patient will be exposed to malaria in Ethiopia.\n\nGiven these factors, the most suitable drug for pre-exposure prophylaxis against malaria would be one that is commonly used and effective in preventing malaria.\n\nThe World Health Organization recommends mefloquine as a first-line medication for chemoprophylaxis of malaria. Therefore, the answer is B: Mefloquine\",\n\"answer_choice\": \"B\""]